Literature DB >> 5416466

Effects of actinomycin D and cycloheximide on RNA and protein synthesis in cleavage stage mouse embryos.

R J Tasca, N Hillman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5416466     DOI: 10.1038/2251022a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  9 in total

1.  Induction of skeletal malformations in organ cultures of mouse limb buds.

Authors:  B Zimmermann; D Neubert; D Bachmann; H J Merker
Journal:  Experientia       Date:  1975-02-15

2.  In vitro development of one-cell embryos from outbred mice: influence of culture medium composition.

Authors:  A Spindle
Journal:  In Vitro Cell Dev Biol       Date:  1990-02

Review 3.  Gene activation during early development of mammals.

Authors:  U Wolf; W Engel
Journal:  Humangenetik       Date:  1972

4.  Mouse intestinal sensitivity to cycloheximide. A morphological, cytochemical and biochemical study.

Authors:  J S Hugon; C Charuel
Journal:  Histochemie       Date:  1971

5.  Studies on the teratogenic phase specificity of actinomycin D in the rat.

Authors:  E Köhler; H J Merker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

6.  Incorporation of Arginine-3H into chromatin of mouse eggs shortly after sperm penetration.

Authors:  V Kopecný; A Pavlok
Journal:  Histochemistry       Date:  1975-12-19

7.  Visualization of Transcription in early mouse embryos.

Authors:  M E Hughes; K Bürki; S Fakan
Journal:  Chromosoma       Date:  1979-08-10       Impact factor: 4.316

8.  Mouse oocytes transcribe injected Xenopus 5S RNA gene.

Authors:  R L Brinster; H Y Chen; M E Trumbauer
Journal:  Science       Date:  1981-01-23       Impact factor: 47.728

9.  Identification of stage-specific polypeptides synthesized during murine preimplantation development.

Authors:  J Levinson; P Goodfellow; M vadeboncoeur; H McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.